To accomplish this, we first intercrossed the mouse mammary tumour virus (MMTV)-activated ErbB2 strain (NDL2-5) to separate strains of mice bearing the MMTV-Cre and conditional FAK alleles and monitored virgin female cohorts for the development of mammary tumours. This evidence concerns the gene ERBB2 and breast cancer.